Close X
Attorney Spotlight

In addition to Mark Manner's busy corporate legal practice, he has established himself as a respected and avid astronomer. Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Blueprint for an IPO

Companies go public to raise capital to fuel growth, pay down debt and provide liquidity to shareholders. Although all issuers and offerings are different, the basic process of going public remains relatively constant. Blueprint for an IPO identifies the key players, details the process and identifies the obligations companies will face after going public.

Read now

Lisa Rivera and Jeff Gibson Author Modern Healthcare Article on Application of Yates Memo within Healthcare Organizations

Modern Healthcare

Publications

November 14, 2016

Bass, Berry & Sims attorneys Lisa Rivera and Jeff Gibson authored a guest column for Modern Healthcare reviewing the directives of the Yates Memo as it impacts investigations related to healthcare fraud and abuse. While Lisa and Jeff contend that the enforcement outlined in the Yates Memo is merely building upon a decades-old position, "[w]hat is new, taking the Yates memo and other Obama administration directives as a whole, is a narrower, more difficult path for healthcare organizations hoping to earn 'cooperation credit' when providing information to the government."

The article also provides several practical steps for healthcare companies to implement in order to cooperate with government investigations:

  1. Creating, implementing and regularly evaluating a robust compliance program
  2. Conducting prompt, thorough internal investigations
  3. Considering the ramifications of any action on all potential enforcement fronts, including possible actions against the individuals managing or making decisions on behalf of the corporation. 

The full article, "Commentary: Raising the Bar on 'Cooperating Fully' with the Government," was published by Modern Healthcare on November 11, 2016, and is available online.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.